Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor John Isaacs

Newcastle AuthorsTitleYearFull text
Professor John Isaacs
Dr Alice Lorenzi
Dr Gary Reynolds
Ross Farley
Helain Hinchcliffe-Hume
et al.		Age, anticoagulants, hypertension and cardiovascular genetic traits predict cranial ischaemic complications in patients with giant cell arteritis2025
Dr Ema-Louise Long
Dr James Stanway
Michael White
Nicola Goudie
Julia Phillipson
et al.		Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis2025
Dr Fiona Rayner
Shaun Hiu
Dr Theophile Bigirumurame
Dr Amy Anderson
Jon Prichard
et al.		Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study2025
Professor John Isaacs
Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis2025
Professor John Isaacs
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials2025
Tegan McTaggart
Dr Jing Xuan Lim
Dr Katie Smith
Bronagh Heaney
Dr David McDonald
et al.		Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease2025
Alice Lin
Dr Alice Lorenzi
Professor John Isaacs
Dr Faye Cooles
Early onset neutropenia in rituximab treated rheumatoid arthritis patients: A case series2025
Dr Faye Cooles
Gemma Vidal Pedrola
Najib Naamane
Dr Arthur Pratt
Dr Ben Barron-Millar
et al.		Endogenous Retroelement Activation is Implicated in Interferon-α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis2025
Professor John Isaacs
Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update2025
Professor John Isaacs
Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole-Blood Transcriptomics Data2025
Dr Leher Gumber
Dr Fiona Rayner
Dr Theophile Bigirumurame
Dr Bernard Dyke
Sean Kerrigan
et al.		Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis2025
Professor John Isaacs
Pretreatment absolute monocyte counts are associated with biological disease-modifying anti-rheumatic drug non-response in patients with rheumatoid arthritis2025
Professor John Isaacs
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis2025
Dr Josh Bennett
Dr Kieren Hollingsworth
Dr Arthur Pratt
Abbie Degnan
Professor Grainne Gorman
et al.		Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single arm, experimental medicine study2025
Professor John Isaacs
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols2025
1234567891011121314151617181920...>>